NuVasive Reports Second Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil, producer inflation weaken
- Oil falls more than 3% on weaker global demand outlook and US crude buildup
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
NuVasive (NUVA) PT Raised to $65 at Leerink Partners Amid Solid Q2
July 29, 2015 7:59 AM EDTLeerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on NuVasive (NASDAQ: NUVA) to $65.00 (from $57.00) following solid Q2 results.
Newitter commented, "NUVA's 2Q was solid with 8.5% cc rev growth & margin/EPS upside. 2015 guidance (rev unchgd; mgn/EPS... More
Brean Capital Raises Price Target on NuVasive (NUVA) Following 2Q EPS Beat
July 29, 2015 7:35 AM EDTBrean Capital reiterated a Buy rating on NuVasive (NASDAQ: NUVA), and raised the price target to $56.00 (from $55.00), following a 2Q15 EPS beat. NUVA reported non-GAAP EPS of $0.31, $0.06 above consensus estimates of $0.25. Revenues for the quarter came in at $202.9M, versus consensus of $200.7M. NUVA... More
Northland Capital Markets Upgrades NuVasive (NUVA) to Outperform
July 29, 2015 7:06 AM EDTNorthland Capital Markets upgraded NuVasive (NASDAQ: NUVA) from Market Perform to Outperform with a price target of $68.00.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $50.47 yesterday.
... MoreNuVasive (NUVA) Tops Q2 EPS by 6c; Enters Settlement with U.S. DOJ
July 28, 2015 4:39 PM EDTNuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.31, $0.06 better than the analyst estimate of $0.25. Revenue for the quarter came in at $202.9 million versus the consensus estimate of $200.71 million.
NuVasive sees FY2015 EPS of $1.17, versus the consensus of $1.12. NuVasive sees FY2015 revenue of $810.0 million, versus the consensus of $812.2 million.
The company also has reached a definitive settlement with the U.S. Department... More
